No doubt the share price has been volatile but taking into account what they have achieved in the last few months and what lies ahead (just to name a few below) it should be a good year.
* Early Jan I think we had 300 patients with 86 registered Healthcare Professionals prescribing Althea products throughout Australia.
* Signed agreement with Cannabis Access Clinics.
* Althea is one of the first medicinal cannabis companies to enter the UK market, Althea is expecting to supply patients in 2019 and in 2020 the product will be supplied by the Australian facility.
Revenues should continue to increase throughout the year and the UK part of the business should ramp up significantly over the next 9 months.
No doubt the share price has been volatile but taking into...
-
- There are more pages in this discussion • 385 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.728M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.4¢ | 2.2¢ | $15.95K | 680.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 609206 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 1006454 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| AGH (ASX) Chart |